News

The Food and Drug Administration (FDA) has approved the MAMMOMAT Inspiration with Tomosynthesis Option – the breast tomosynthesis add-on option for Siemens Healthcare’s MAMMOMAT Inspiration ...
"Siemens is proud to announce the availability of 3-D-only screening with our Mammomat Inspiration with Tomosynthesis Option digital mammography system," said Martin Silverman, VP of X-ray ...
--(BUSINESS WIRE)--Siemens Healthcare has announced that it recently submitted to the U.S. Food and Drug Administration (FDA) its premarket approval application (PMA) for the MAMMOMAT Inspiration ...
The Siemens approval for its Mammomat Inspiration with Tomosynthesis Option is the latest advance for the 3-D imaging technology. In 2011, breast tomosynthesis kicked off with an approval for Hologic.